Compensatory hyperhidrosis: a consequence of truncal sympathectomy treated by video assisted application of botulinum toxin and reoperation

Efthymiou, Christopher Andrew; Thorpe, James Andrew Charles
June 2008
European Journal of Cardio-Thoracic Surgery;Jun2008, Vol. 33 Issue 6, p1157
Academic Journal
Abstract: Hyperhidrosis is a debilitating condition characterised by sweating that exceeds the need of normal thermoregulation. Surgical management of primary hyperhidrosis by upper dorsal sympathectomy is the treatment of choice for intractable hyperhidrosis, however, paradoxically it may be followed by troublesome compensatory hyperhidrosis in a significant number of patients. The frequency of compensatory hyperhidrosis often reflects the extensiveness of the denervation. We report for the first time the successful treatment of a patient who developed compensatory hyperhidrosis following sympathectomy using video assisted extension of the sympathectomy by application of botulinum toxin (BTX-A). In addition, this case highlights the use of botulinum toxin as a guide for the potential successful management of compensatory hyperhidrosis prior to definitive extension of a sympathectomy.


Related Articles

  • The value of local botulinum toxin A injection in the treatment of the pain of aphthous ulcer. Tae Yong Yang; Tae Yong Jang // European Archives of Oto-Rhino-Laryngology;Mar2009, Vol. 266 Issue 3, p445 

    To determine the effectiveness of botulinum toxin type A to reduce pain of recurrent aphthous ulcer, a single blinded placebo controlled trial of botulinum toxin A injection was performed. A total of 70 patients were enrolled and randomly received a botulinum toxin type A 1 unit or placebo. The...

  • How to obtain optimum results with botulinum toxin. Charles, Lynda // Ophthalmology Times;5/1/2004, Vol. 29 Issue 9, p64 

    Shows how ophthalmologists can obtain the best results with botulinum toxin injections. Goals of cosmetic botulinum toxin ; Pre-procedure assessment; Correct dosage; Depth of injections; Other requirements for doing the procedure correctly.

  • Botulinum Toxin A: Its Expanding Role in Dermatology and Esthetics. Said, Samireh Z.; Meshkinpour, Azin; Carruthers, Alastair; Carruthers, Jean // American Journal of Clinical Dermatology;2003, Vol. 4 Issue 9, p609 

    The use of botulinum toxin A in cosmetic dermatology has increased in popularity due to the efficacy and relative safety of the treatment. Botulinum toxin A is one of eight exotoxins produced by Clostridium botulinum, a Gram-positive, spore-forming anaerobe. Flaccid paralysis results from the...

  • Botulinum Toxin: A Successful Therapeutic Protein. Aoki, K. Roger // Current Medicinal Chemistry;Dec2004, Vol. 11 Issue 23, p3085 

    Botulinum toxin serotype A has proven to be a successful and valuable therapeutic protein when dosage, frequency of treatment and variety of treated clinical conditions are considered. This modern therapeutic protein was predicted by Justinus Kerner, a 19th century German physician, who provided...

  • Sheep Monoclonal Antibodies Prevent Systemic Effects of Botulinum Neurotoxin A1. Mukherjee, Jean; McCann, Chase; Ofori, Kwasi; Hill, Julia; Baldwin, Karen; Shoemaker, Charles B.; Harrison, Peter; Tzipori, Saul // Toxins;Dec2012, Vol. 4 Issue 12, p1565 

    Botulinum neurotoxin (BoNT) is responsible for causing botulism, a potentially fatal disease characterized by paralysis of skeletal muscle. Existing specific treatments include polyclonal antisera derived from immunized humans or horses. Both preparations have similar drawbacks, including...

  • Botulinum toxin type A in experimental neuropathic pain. Bach-Rojecky, L.; Relja, M.; Lacković, Z. // Journal of Neural Transmission;Feb2005, Vol. 112 Issue 2, p215 

    A peripheral application of botulinum toxin type A (7?U/kg) has significantly reduced thermal and mechanical hypersensitivity in rats with the partial sciatic nerve transection as a classical model of surgical neuropathy.

  • Botulinum toxin in the management of acquired motor fusion deficiency. Murthy, Ramesh; Kesarwani, Siddharth // Indian Journal of Ophthalmology;Dec2009, Vol. 57 Issue 6, p463 

    Acquired disruption of motor fusion is a rare condition characterized by intractable diplopia. Management of these patients is extremely difficult. Prisms in any combination or even surgery may not help relieve their symptoms. We describe a longstanding case of acquired motor fusion disruption...

  • Fillers beef up botulinum toxin results. Bryant, Rebecca // Dermatology Times;Oct2004, Vol. 25 Issue 10, p63 

    The article reports that botulinum toxin combined with fillers produces elegant, synergistic results. Aging is caused by photodamage, hyperactive muscles and volume loss. By combining botulinum and fillers, one attacks the problem on two of the three fronts. Botox eliminates the muscular...

  • Botulinum Toxin for Suspected Pseudoachalasia. Vallera, Raymond A.; Brazer, Scott R. // American Journal of Gastroenterology;Aug1995, Vol. 90 Issue 8, p1319 

    We describe a 74-yr-old man with stage III adenocarcinoma of the lung who presented with suspected malignancy-induced secondary achalasia and responded clinically to intrasphincteric injections of botulinum toxin type A (Botox, Allergen Inc., Irvine, CA). We discuss the use of botulinum toxin in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics